Skip to main content
. Author manuscript; available in PMC: 2012 Mar 15.
Published in final edited form as: Cancer Res. 2011 Jan 31;71(6):2066–2076. doi: 10.1158/0008-5472.CAN-10-3200

Fig 7. scFv-NKG2D treatment significantly increases T cell infiltration in a B16F10 melanoma model.

Fig 7

Infiltration of CD4+ (A) and CD8+ (C) T cells was analyzed by flow cytometry on excised B16F10 tumor tissues 19 days post-inoculation. Results shown are pooled data from two independent experiments and are demonstrated as fold-increase, in which the average % in the WT B16F10-injected group was designated as 1. *: p<0.01. CD69 expression on CD4+ (B) and CD8+ (D) T cells was also analyzed.